NCT03354650

Brief Summary

Neonatal sepsis is an important cause of morbidity and mortality in the pediatric age group . It is one of the leading causes of death in the first 28 days of life both in the developed and developing countries.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 28, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

December 5, 2017

Status Verified

November 1, 2017

Enrollment Period

1 year

First QC Date

October 28, 2017

Last Update Submit

December 3, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Incidence of neonatal sepsis

    by measuring the incidence of neonatal sepsis helping to know the size of the problem of neonatal sepsis

    up to 4 months

  • prevalence of neonatal sepsis

    by measuring the prevalence of neonatal sepsis this help us to manage neonatal sepsis accordingly

    up to 4 months

Secondary Outcomes (1)

  • risk factors and causative organisms of neonatal sepsis

    up to 4 months

Study Arms (2)

complete blood count

blood sample is collected from infant to detect presence of sepsis

Diagnostic Test: blood culture

c reactive protein

measuring c reactive protein in blood sample to determine neonatal sepsis

Diagnostic Test: blood culture

Interventions

blood cultureDIAGNOSTIC_TEST

blood culture to determine causative organisms of neonatal sepsis

Also known as: other cultures if needed
c reactive proteincomplete blood count

Eligibility Criteria

AgeUp to 4 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

All admitted male and female infant from the birth to the day 30 after birth

You may qualify if:

  • All admitted inborn and out born neonates during this study period will be screened for sepsis

You may not qualify if:

  • All cases that mimic neonatal sepsis such as;
  • Inborn errors of metabolism
  • Congestive heart failure
  • Hemolytic Disease of Newborn
  • Hypoxic ischemic encephalopathy
  • Congenital Diaphragmatic Hernia
  • Intra cranial hemorrhage
  • Respiratory Distress Syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neonatal Sepsis

Interventions

Blood Culture

Condition Hierarchy (Ancestors)

SepsisInfectionsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Microbiological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Gehan Mo Kamal El_Din, Professor

    Assiut University

    STUDY CHAIR

Central Study Contacts

Ghan M Kamal El_Din, Professor

CONTACT

Ismael L Mohammed, Assistant Pr

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 28, 2017

First Posted

November 28, 2017

Study Start

January 1, 2018

Primary Completion

January 1, 2019

Study Completion

July 1, 2019

Last Updated

December 5, 2017

Record last verified: 2017-11